The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
CSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291
Self-citationGoedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037
Ubiquitin Is a Component of Paired Helical Filaments in Alzheimer's Disease
Mori, H., Kondo, J., & Ihara, Y. (1987) · Science · doi:10.1126/science.3029875 · Cited by 843
Blennow, K., Wallin, A., Ågren, H., Spenger, C., Siegfried, J., & Vanmechelen, E. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815140 · Cited by 789
Self-citationImproved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., Deyn, P. P. D., Bancher, C., Cras, P., Wiltfang, J., Mehta, P. D., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1555 · Cited by 724
Self-citationAltered expression of synaptic proteins occurs early during progression of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.1.127 · Cited by 720
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
Motter, R., Vigo‐Pelfrey, C., Kholodenko, D., Barbour, R., Johnson‐Wood, K., Galasko, D., Chang, L., Miller, B., Clark, C., Green, R., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380413 · Cited by 701
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Andreasen, N., Hesse, C., Davidsson, P., Minthon, L., Wallin, A., Winblad, B., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.673 · Cited by 660
Self-citationSunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656
Perry, G., Friedman, R., Shaw, G., & Chau, V (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3033 · Cited by 623 · cited 2×
“In AD brain, the paired helical filaments (PHF) in tangles are ubiquitinated.(117,118) The level of ubiquitin in AD cerebral cortex is increased several-fold and correlates with the amount of neurofibrillary changes.”
BackgroundResultCSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
Strozyk, D., Blennow, K., White, L. R., & Launer, L. J. (2003) · Neurology · doi:10.1212/01.wnl.0000046581.81650.d0 · Cited by 612
Self-citationPlasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease
Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
Andreasen, N., Minthon, L., Davidsson, P., Vanmechelen, E., Vanderstichele, H., Winblad, B., & Blennow, K. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.373 · Cited by 573
Self-citationMild cognitive impairment: prevalence, prognosis, aetiology, and treatment
DeCarli, C. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00262-x · Cited by 573
Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice
Friede, R. L., & Samorajski, T. (1970) · The Anatomical Record · doi:10.1002/ar.1091670402 · Cited by 536
Miller, D. L., Papayannopoulos, I. A., Styles, J., Bobin, S. A., Lin, Y. Y., Biemann, K., & Iqbal, K. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1112 · Cited by 510
Vandermeeren, M., Mercken, M., Vanmechelen, E., Six, J., Van de Voorde, A., Martin, J., & Cras, P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09823.x · Cited by 495
Vanmechelen, E., Vanderstichele, H., Davidsson, P., Van Kerschaver, E., Van Der Perre, B., Sjögren, M., Andreasen, N., & Blennow, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01036-3 · Cited by 488
Self-citationIda, N., Hartmann, T., Pantel, J., Schrüder, J., Zerfass, R., Fürstl, H., Sandbrink, R., Masters, C. L., & Beyreuther, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22908 · Cited by 478
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
Hesse, C., Rosengren, L., Andreasen, N., Davidsson, P., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01697-9 · Cited by 450
Self-citationGalasko, D., Chang, L., Motter, R., Clark, C. M., Kaye, J., Knopman, D., Thomas, R., Kholodenko, D., Schenk, D., Lieberburg, I., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.937 · Cited by 442
Hampel, H., Buerger, K., Zinkowski, R., Teipel, S. J., Goernitz, A., Andreasen, N., Sjoegren, M., DeBernardis, J., Kerkman, D., Ishiguro, K., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.95 · Cited by 434
Self-citationGrundke-Iqbal, I., Iqbal, K., Tung, Y.-C., Quinlan, M., Wisniewski, H., & Binder, L. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701030-00020 · Cited by 410
Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid
Vigo‐Pelfrey, C., Lee, D., Keim, P., Lieberburg, I., & Schenk, D. B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09841.x · Cited by 385
Davies, L., Wolska, B., Hilbich, C., Multhaup, G., Martins, R., Simms, G., Beyreuther, K., & Masters, C. L. (1988) · Neurology · doi:10.1212/wnl.38.11.1688 · Cited by 369
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
Otto, M., Wiltfang, J., Tumani, H., Zerr, I., Lantsch, M., Kornhuber, J., Weber, T., Kretzschmar, H. A., & Poser, S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00215-2 · Cited by 341
Kanai, M., Matsubara, E., Isoe, K., Urakami, K., Nakashima, K., Arai, H., Sasaki, H., Abe, K., Iwatsubo, T., Kosaka, T., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440108 · Cited by 340
The ubiquitin system: functions and mechanisms
Finley, D., & Varshavsky, A. (1985) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(85)90108-2 · Cited by 302
Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease
Arai, H., Terajima, M., Miura, M., Higuchi, S., Muramatsu, T., Machida, N., Seiki, H., Takase, S., Clark, C. M., Lee, V. M. ‐., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380414 · Cited by 298
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease
Otto, M., Wiltfang, J., Cepek, L., Neumann, M., Mollenhauer, B., Steinacker, P., Ciesielczyk, B., Schulz–Schaeffer, W., Kretzschmar, H. A., & Poser, S. (2002) · Neurology · doi:10.1212/wnl.58.2.192 · Cited by 289
Buerger, K., Zinkowski, R., Teipel, S. J., Tapiola, T., Arai, H., Blennow, K., Andreasen, N., Hofmann-Kiefer, K., DeBernardis, J., Kerkman, D., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.8.1267 · Cited by 277
Self-citationWiltfang, J., Esselmann, H., Bibl, M., Smirnov, A., Otto, M., Paul, S., Schmidt, B., Klafki, H. ‐., Maler, M., Dyrks, T., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00818.x · Cited by 271
CSF Total tau, Aβ42 and Phosphorylated tau Protein as Biomarkers for Alzheimer's Disease
Blennow, K., Vanmechelen, E., & Hampel, H. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:087 · Cited by 267
Self-citationItoh, N., Arai, H., Urakami, K., Ishiguro, K., Ohno, H., Hampel, H., Buerger, K., Wiltfang, J., Otto, M., Kretzschmar, H., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1054 · Cited by 256
Both total and phosphorylated tau are increased in Alzheimer's disease
Sjogren, M. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.5.624 · Cited by 253
Patterns of aberrant sprouting in alzheimer's disease
Masliah, E., Mallory, M., Hansen, L., Alford, M., Albright, T., DeTeresa, R., Terry, R., Baudier, J., & Saitoh, T. (1991) · Neuron · doi:10.1016/0896-6273(91)90170-5 · Cited by 244
Andreasen, N., Minthon, L., Vanmechelen, E., Vanderstichele, H., Davidsson, P., Winblad, B., & Blennow, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00617-5 · Cited by 239
Self-citationSjögren, M., Minthon, L., Davidsson, P., Granérus, A. K., Clarberg, A., Vanderstichele, H., Vanmechelen, E., Wallin, A., & Blennow, K. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070079 · Cited by 239
Self-citationRiemenschneider, M., Wagenpfeil, S., Vanderstichele, H., Otto, M., Wiltfang, J., Kretzschmar, H., Vanmechelen, E., Förstl, H., & Kurz, A. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001220 · Cited by 238 · cited 9×
“A study with longitudinal magnetic resonance tomography (MRT) scans in VAD cases20 also found that VAD cases with progressive white-matter changes have normal CSF T-tau.”
BackgroundResultInfluentialAndreasen, N., Vanmechelen, E., Van de Voorde, A., Davidsson, P., Hesse, C., Tarvonen, S., Raiha, I., Sourander, L., Winblad, B., & Blennow, K. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.298 · Cited by 227
Self-citationVigo-Pelfrey, C., Seubert, P. P., Barbour, R., Blomquist, C., Lee, M., Lee, D., Coria, F., Chang, L., Miller, B., Lieberburg, I., et al. (1995) · Neurology · doi:10.1212/wnl.45.4.788 · Cited by 225
Combination assay of CSF Tau, Aβ1-40 and Aβ1-42(43) as a biochemical marker of Alzheimer's disease
Shoji, M., Matsubara, E., Kanai, M., Watanabe, M., Nakamura, T., Tomidokoro, Y., Shizuka, M., Wakabayashi, K., Igeta, Y., Ikeda, Y., et al. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00122-1 · Cited by 221
Sergeant, N., Bombois, S., Ghestem, A., Drobecq, H., Kostanjevecki, V., Missiaen, C., Wattez, A., David, J., Vanmechelen, E., Sergheraert, C., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01818.x · Cited by 218
Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke
Hesse, C., Rosengren, L., Vanmechelen, E., Vanderstichele, H., Jensen, C., Davidsson, P., & Blennow, K. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-23-402 · Cited by 216
Self-citationThe Ubiquitin Pathway for the Degradation of Intracellular Proteins
Hershko, A., & Ciechanover, A. (1986) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60019-7 · Cited by 215
Riemenschneider, M., Lautenschlager, N., Wagenpfeil, S., Diehl, J., Drzezga, A., & Kurz, A. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1729 · Cited by 215
Jensen, M., Schr�der, J., Blomberg, M., Engvall, B., Pantel, J., Ida, N., Basun, H., Wahlund, L.-O., Werle, E., Jauss, M., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199904)45:4<504::aid-ana12>3.0.co;2-9 · Cited by 214
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
Andreasen, N., Minthon, L., Clarberg, A., Davidsson, P., Gottfries, J., Vanmechelen, E., Vanderstichele, H., Winblad, B., & Blennow, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1488 · Cited by 212
Self-citationSpecific changes in rapidly transported proteins during regeneration of the goldfish optic nerve
Benowitz, L., Shashoua, V., & Yoon, M. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-03-00300.1981 · Cited by 209
Neurofilament protein in cerebrospinal fluid: A marker of white matter changes
Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. ‐., Edman, Å., Lind, K., Rosengren, L., Blennow, K., & Wallin, A. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1242 · Cited by 209
Self-citationVan Nostrand, W. E., Wagner, S. L., Shankle, W. R., Farrow, J. S., Dick, M., Rozemuller, J. M., Kuiper, M. A., Wolters, E. C., Zimmerman, J., & Cotman, C. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2551 · Cited by 208
Maddalena, A., Papassotiropoulos, A., Müller-Tillmanns, B., Jung, H. H., Hegi, T., Nitsch, R. M., & Hock, C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.9.1202 · Cited by 204
Alzheimer's Disease: Biology, Diagnosis and Therapeutics
Hier, D. B. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00025 · Cited by 198
Skoog, I., Davidsson, P., Aevarsson, Ó., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000068478 · Cited by 194
Self-citationCSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
Buerger, K., Teipel, S. J., Zinkowski, R., Blennow, K., Arai, H., Engel, R., Hofmann–Kiefer, K., McCulloch, C., Ptok, U., Heun, R., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.627 · Cited by 187
Self-citationNeurochemical Dissection of Synaptic Pathology in Alzheimer's Disease
Davidsson, P., & Blennow, K. (1998) · International Psychogeriatrics · doi:10.1017/s1041610298005110 · Cited by 182
Self-citationCytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
Sjögren, M., Rosengren, L., Minthon, L., Davidsson, P., Blennow, K., & Wallin, A. (2000) · Neurology · doi:10.1212/wnl.54.10.1960 · Cited by 181
Self-citationHu, Y. Y., He, S. S., Wang, X., Duan, Q. H., Grundke-Iqbal, I., Iqbal, K., & Wang, J. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62554-0 · Cited by 181
Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease
Ishiguro, K., Ohno, H., Arai, H., Yamaguchi, H., Urakami, K., Park, J.-M., Sato, K., Kohno, H., & Imahori, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00476-0 · Cited by 175
Kohnken, R., Buerger, K., Zinkowski, R., Miller, C., Kerkman, D., DeBernardis, J., Shen, J., Möller, H.-J., Davies, P., & Hampel, H. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01178-2 · Cited by 173
Decreased β-amyloid 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Otto, M., Esselmann, H., Schulz-Schaeffer, W., Neumann, M., Schröter, A., Ratzka, P., Cepek, L., Zerr, I., Steinacker, P., Windl, O., et al. (2000) · Neurology · doi:10.1212/wnl.54.5.1099 · Cited by 171
Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies
Kanemaru, K., Kameda, N., & Yamanouchi, H. (2000) · Neurology · doi:10.1212/wnl.54.9.1875 · Cited by 170
Tau and Aβ42 protein in CSF of patients with frontotemporal degeneration
Riemenschneider, M., Wagenpfeil, S., Diehl, J., Lautenschlager, N., Theml, T., Heldmann, B., Drzezga, A., Jahn, T., Förstl, H., & Kurz, A. (2002) · Neurology · doi:10.1212/wnl.58.11.1622 · Cited by 168
Nixon, R. A. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00723.x · Cited by 161
Andreasen, N., Vanmechelen, E., Vanderstichele, H., Davidsson, P., & Blennow, K. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.107.s179.9.x · Cited by 160
Self-citationSjögren, M. J. C., Davidsson, P., Wallin, A., Granérus, A., Grundström, E., Askmark, H., Vanmechelen, E., & Blennow, K. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000048642 · Cited by 160
Self-citationNeurofilament protein levels in CSF are increased in dementia
Rosengren, L., Karlsson, J. E., Sjögren, M. J. C., Blennow, K., & Wallin, A. (1999) · Neurology · doi:10.1212/wnl.52.5.1090 · Cited by 160
Self-citationCerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
Arai, H., Morikawa, Y.-I., Higuchi, M., Matsui, T., Clark, C. M., Miura, M., Machida, N., Lee, V. M.-Y., Trojanowski, J. Q., & Sasaki, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6908 · Cited by 159
Alzheimer's disease : biology, diagnosis, and therapeutics
Iqbal, K., & Disorders, R. (1996) · SDÜ Bilgi Merkezi · Cited by 153
Localization of the growth-associated phosphoprotein GAP-43 (B-50, F1) in the human cerebral cortex
Benowitz, L. I., Perrone-Bizzozero, N., Finklestein, S. P., & Bird, E. D. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-03-00990.1989 · Cited by 153
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease
Galasko, D. R., Clark, C., Chang, L., Miller, B. L., Green, R. C., Motter, R. N., & Seubert, P. A. (1997) · Neurology · doi:10.1212/wnl.48.3.632 · Cited by 151
Kapaki, E., Kilidireas, K., Paraskevas, G. P., Michalopoulou, M., & Patsouris, E. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.3.401 · Cited by 144
Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease
Tamaoka, A., Sawamura, N., Fukushima, T., Shoji, S., Matsubara, E., Shoji, M., Hirai, S., Furiya, Y., Endoh, R., & Mori, H. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00314-0 · Cited by 144
Parnetti, L., Lanari, A., Amici, S., Gallai, V., Vanmechelen, E., & Hulstaert, F. (2001) · Neurological Sciences · doi:10.1007/s100720170055 · Cited by 141
Mori, H., Hosoda, K., Matsubara, E., Nakamoto, T., Furiya, Y., Endoh, R., Usami, M., Shoji, M., Maruyama, S., & Hirai, S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11291-4 · Cited by 140
Cerebrospinal Fluid Markers in Dementia With Lewy Bodies Compared With Alzheimer Disease
Gómez‐Tortosa, E., Gonzalo, I., Fanjul, S., Sainz, M. J., Cantarero, S., Cemillán, C. A., de Yébenes, J. G., & del Ser, T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.9.1218 · Cited by 135
Fukuyama, R., Mizuno, T., Mizuno, T., Mori, S., Nakajima, K., Fushiki, S., & Yanagisawa, K. (2000) · European Neurology · doi:10.1159/000008156 · Cited by 128
Soluble Amyloid β-Protein Is a Marker of Alzheimer Amyloid in Brain But Not in Cerebrospinal Fluid
Tabaton, M., Nunzi, M. G., Xue, R., Usiak, M., AUTILIO‐GAMBETTI, L., & Gambetti, P. L. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1634 · Cited by 126
CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective Study
Arai, H., Ishiguro, K., Ohno, H., Moriyama, M., Itoh, N., Okamura, N., Matsui, T., Morikawa, Y.-I., Horikawa, E., Kohno, H., et al. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7501 · Cited by 123
Diagnostic accuracy of alzheimer’s disease: A neuropathological study
Kosunen, O., Soininen, H. S., Paljärvi, L., Heinonen, O., Talasniemi, S., & Riekkinen, P. J. (1996) · Acta Neuropathologica · doi:10.1007/s004010050412 · Cited by 122
Sjögren, M. J. C., Davidsson, P., Gottfries, J., Vanderstichele, H., Edman, Å., Vanmechelen, E., Wallin, A., & Blennow, K. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051268 · Cited by 121
Self-citationde la Monte, S. M., Ghanbari, K., Frey, W. H., Beheshti, I., Averback, P., Hauser, S. L., Ghanbari, H. A., & Wands, J. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119864 · Cited by 120
Holmberg, B., Johnels, B., Blennow, K., & Rosengren, L. (2002) · Movement Disorders · doi:10.1002/mds.10321 · Cited by 116
Self-citationHu, Y., Shanshu, H., Wang, X., Duan, Q., Khatoon, S., Iqbal, K., Grundke, I., & Wang, J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00047-2 · Cited by 115
Lewczuk, P., Esselmann, H., Meyer, M., Wollscheid, V., Neumann, M., Otto, M., Maler, J. M., Rüther, E., Kornhuber, J., & Wiltfang, J. (2003) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1048 · Cited by 108
Alzheimer neurofibrillary tangles: Monoclonal antibodies to inherent antigen(s)
Wang, G. P., Grundke, I., Kascsak, R., Iqbal, K., & Wisniewski, H. M. (1984) · Acta Neuropathologica · doi:10.1007/bf00687608 · Cited by 103
Tamaoka, A., Kondo, T., Odaka, A., Sahara, N., Sawamura, N., Ozawa, K., Suzuki, N., Shoji, S., & Mori, H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2740 · Cited by 101
Combined assessment of tau and neuronal thread protein in Alzheimer’s disease CSF
Kahle, P. J., Jakowec, M. W., Teipel, S. J., Hampel, H. J., Petzinger, G. M., Monte, D. A. D., Silverberg, G. D., Möller, H. ‐., Yesavage, J. A., Tinklenberg, J. R., et al. (2000) · Neurology · doi:10.1212/wnl.54.7.1498 · Cited by 101
Brain ubiquitin is markedly elevated in Alzheimer disease
Wang, G. P., Khatoon, S., Iqbal, K., & Grundke, I. (1991) · Brain Research · doi:10.1016/0006-8993(91)91692-t · Cited by 100
Maruyama, M., Arai, H., Sugita, M., Tanji, H., Higuchi, M., Okamura, N., Matsui, T., Higuchi, S., Matsushita, S., Yoshida, H., et al. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7814 · Cited by 97
Büerger, K., Zinkowski, R. P., Teipel, S. J., Arai, H., DeBernardis, J. F., Kerkman, D. J., McCulloch, C., Padberg, F., Faltraco, F., Goernitz, A., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.376 · Cited by 94
Kapaki, E., Paraskevas, G. P., Zalonis, I., & Zournas, C. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00562.x · Cited by 91
Davidsson, P., Puchades, M. A., & Blennow, K. (1999) · Electrophoresis · Cited by 91
Self-citationCerebrospinal protein tau is elevated in early Alzheimer's disease
Riemenschneider, M. J., Buch, K., Schmolke, M., Kurz, A., & Guder, W. G. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12810-x · Cited by 90
Southwick, P. C., Yamagata, S. K., Echols, C. L., Higson, G. J., Neynaber, S. A., Parson, R. E., & Munroe, W. A. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010259.x · Cited by 89
Combined assessment of tau and neuronal thread protein in Alzheimer’s disease CSF
Averback, P. (2000) · Neurology · doi:10.1212/wnl.55.7.1068 · Cited by 89
Progress in Alzheimer’s and Parkinson’s Diseases
(1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3 · Cited by 86
New Perspectives on the Structure and Function of Ubiquitin
Monia, B. P., Ecker, D. J., & Crooke, S. T. (1990) · Nature Biotechnology · doi:10.1038/nbt0390-209 · Cited by 85
Kurz, A., Riemenschneider, M., Buch, K., Willoch, F., Bartenstein, P., Müller, U., & Guder, W. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199812000-00020 · Cited by 85
Concentrations of amyloid β protein in cerebrospinal fluid of patients with alzheimer's disease
van Gool, W. A., Walstra, G. J. M., Bolhuis, P. A., Kuiper, M. A., & Wolters, E. C. (1995) · Annals of Neurology · doi:10.1002/ana.410370221 · Cited by 82
Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels
Kudo, T., Iqbal, K., Ravid, R., Swaab, D. F., & Grundke, I. (1994) · Brain Research · doi:10.1016/0006-8993(94)91757-4 · Cited by 82
Tau Protein in Cerebrospinal Fluid
Mecocci, P., Cherubini, A., Bregnocchi, M., Chionne, F., Cecchetti, R., Lowenthal, D. T., & Senin, U. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00015 · Cited by 81
Rosso, S. M., van Herpen, E., Pijnenburg, Y. A. L., Schoonenboom, N. S. M., Scheltens, P., Heutink, P., & Swieten, J. C. V. (2003) · Archives of Neurology · doi:10.1001/archneur.60.9.1209 · Cited by 78
Burns, A. S., Tomlinson, B. E., & Mann, D. M. A. (1997) · PubMed · Cited by 77
Shoji, M., Matsubara, E., Murakami, T., Manabe, Y., Abe, K., Kanai, M., Ikeda, M., Tomidokoro, Y., Shizuka, M., Watanabe, M., et al. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00309-8 · Cited by 74
Development of a Specific Diagnostic Test for Measurement of β-Amyloid (1-42) [βA4(l-42)] in CSF
Vanderstichele, H., Blennow, K., D'Heuvaert, N., Buyse, M.-A., Wallin, A., Andreasen, N. C., Seubert, P. A., VOORDE, A. V. D., & Vanmechelen, E. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_110 · Cited by 70
Self-citationPerry, G. L., Mulvihill, P., Fried, V. A., Smith, H. T., Grundke, I., & Iqbal, K. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09203.x · Cited by 69
Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach
Iqbal, K., del Alonso, A. C., Gondal, J. A., Gong, C., Haque, N., Khatoon, S., Sengupta, A., Wang, J.-Z., & Grundke, I. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_22 · Cited by 68
Lautenschlager, N. T., Riemenschneider, M., Drzezga, A. E., & Kurz, A. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051284 · Cited by 67
Bogdanović, N., Davidsson, P., Volkmann, I., Winblad, B. G., & Blennow, K. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070088 · Cited by 66
Self-citationDiagnostic accuracy of Alzheimer’s disease: A clinicopathological study
Jellinger, K. A. (1996) · Acta Neuropathologica · doi:10.1007/s004010050418 · Cited by 64
Sáez‐Valero, J., Fodero, L. R., Sjögren, M. J. C., Andreasen, N. C., Amici, S., Gallai, V., Vanderstichele, H., Vanmechelen, E., Parnetti, L., Blennow, K., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10599 · Cited by 63
Self-citationClinical Heterogeneity of Probable Alzheimer's Disease
Blennow, K., & Wallin, A. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500208 · Cited by 63
Self-citationElevated levels of an exocrine pancreatic secretory protein in Alzheimer disease brain.
Öztürk, M., de la Monte, S. M., Gross, J., & Wands, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.419 · Cited by 61
Mercken, M. H., Lübke, U., Vandermeeren, M., Gheuens, J., & Oestreicher, A. B. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230310 · Cited by 59
Farlow, M. R., Ghetti, B., Benson, M. D., Farrow, J. S., van Nostrand, W. E., & Wagner, S. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)91771-y · Cited by 58
Nishimura, T., Takeda, M., NAKAMURA, Y., & al., E. (1998) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.1998.20.3.485673 · Cited by 56
Schröder, J., Pantel, J., Ida, N., Essig, M., Hartmann, T., Knopp, M. V., Schad, L. R., Sandbrink, R., Sauer, H., Masters, C. L., et al. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000313 · Cited by 55
Rösler, N., Wichart, I., & Jellinger, K. A. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170091 · Cited by 51
No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia
Arai, H., Satoh‐Nakagawa, T., Higuchi, M., Morikawa, Y.-I., Miura, M., Kawakami, H., Seki, H., Takase, S., & Sasaki, H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00781-2 · Cited by 51
Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics.
Morikawa, Y., Arai, H., Matsushita, S., Kato, M., Higuchi, S., Miura, M., Kawakami, H., Higuchi, M., Okamura, N., Tashiro, M., et al. (1999) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04156.x · Cited by 49
Molina, L., Touchon, J., Herpé, M., Lefranc, D., Duplan, L., Cristol, J., Sabatier, R., Vermersch, P., Pau, B., & Mourton-Gilles, C. (1999) · Neuroreport · doi:10.1097/00001756-199911260-00005 · Cited by 49
de la Monte, S. M., Volicer, L., Hauser, S. L., & Wands, J. R. (1992) · Annals of Neurology · doi:10.1002/ana.410320606 · Cited by 49
Wallin, A., Sjögren, M. J. C., Blennow, K., & Davidsson, P. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000072803 · Cited by 47
Self-citationAlzheimer's disease: paired helical filament immunoreactivity in cerebrospinal fluid
Wang, G. P., Iqbal, K., Bucht, G., Winblad, B. G., Wisniewski, H. M., & Grundke, I. (1991) · Acta Neuropathologica · doi:10.1007/bf00310917 · Cited by 46
Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease
Everbroeck, B. V. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.1.79 · Cited by 45
CSF markers related to pathogenetic mechanisms in Alzheimer's disease
Mulder, C., Schoonenboom, S. N. M., Wahlund, L., Scheltens, P., van Kamp, G. J., Veerhuis, R., Hack, C. E., Blomberg, M. E., Schutgens, R. B. H., & Eikelenboom, P. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-002-0763-y · Cited by 43
Ubiquitin in Cerebrospinal Fluid in Alzheimer ’s Disease and Vascular Dementia
Blennow, K., Davidsson, P., Wallin, A., Gottfries, C., & Svennerholm, L. T. (1994) · International Psychogeriatrics · doi:10.1017/s1041610294001584 · Cited by 40
Self-citationGottfries, J., Blennow, K., Lehmann, M., Regland, B., & Gottfries, C. G. (2001) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870101400302 · Cited by 35
Self-citationThe drops of life: fluids and electrolytes.
Ma, B., & Cb, K. (1970) · PubMed · Cited by 34
A sandwich enzyme immunoassay for measuring AD7C-NTP as an Alzheimer's disease marker: AD7C test
Ghanbari, K., & Ghanbari, H. A. (1998) · Journal of Clinical Laboratory Analysis · doi:10.1002/(sici)1098-2825(1998)12:4<223::aid-jcla6>3.0.co;2-8 · Cited by 33
Neuronal thread protein over-expression in brains with Alzheimer's disease lesions
de la Monte, S. M., & Wands, J. R. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90243-e · Cited by 30
PAIRED HELICAL FILAMENT ANTIGEN IN CSF
Mehta, P. D., Thal, L. J., Wisniewski, H. M., Grundke, I., & Iqbal, K. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90074-1 · Cited by 29
Andreasen, N. C. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.557 · Cited by 29
Blennow, K., Wallin, A., & Chong, J. K. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0023 · Cited by 20
Self-citationBriani, C., Ruggero, S., Naccarato, M., Cagnin, A., Ricchieri, G., Pasqui, L., Pizzolato, G., & Battistin, L. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200031 · Cited by 16
Genetic testing for Alzheimerʼs disease: how close is reality?
Blennow, K., & Skoog, I. G. (1999) · Current Opinion in Psychiatry · doi:10.1097/00001504-199907000-00019 · Cited by 16
Self-citationPharmacological targets to inhibit alzheimer neurofibrillary degeneration
Iqbal, K., del Alonso, A. C., El-Akkad, E., Gong, C., Haque, N., Khatoon, S., Tsujio, I., & Grundke, I. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_29 · Cited by 15
Takeda, M., Tanaka, T., Arai, H., Sasaki, H., Shoji, M., Okamoto, K., Urakami, K., Nakashima, K., Matsubayashi, T., Sugita, M., et al. (2001) · Psychogeriatrics · doi:10.1111/j.1479-8301.2001.tb00073.x · Cited by 11
Cited by
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Self-citationCerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Self-citationBiomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Hampel, H., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 631
Self-citationSuppression of glymphatic fluid transport in a mouse model of Alzheimer's disease
Peng, W., Achariyar, T. M., Li, B., Liao, Y., Mestre, H., Hitomi, E., Regan, S., Kasper, T., Peng, S., Ding, F., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.015 · Cited by 580
Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases
Irvine, G. B., El-Agnaf, O. M., Shankar, G. M., & Walsh, D. M. (2008) · Molecular Medicine · doi:10.2119/2007-00100.irvine · Cited by 550
Metadata
- Authors
- Blennow, K.
- Venue
- NeuroRX
- Published
- 2004-04
- Volume
- 1
- Issue
- 2
- Pages
- 213-225
- ISSN
- 1545-5343 (ISSN-L)
- OpenAlex
- W2057236704
- Cited by
- 477
- References
- 150
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.